CureVac To Be Shut Down Following BioNTech Acquisition
BioNTech is expected to shut down CureVac completely following its acquisition of the company. The acquisition followed previous patent infringement allegations made by CureVac against BioNTech regarding mRNA technology.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
hr-iNFO
“Seit gestern wissen wir, CureVac wird komplett dicht gemacht. Man braucht ja jetzt logischerweise auch nicht mehr so viele Corona-Impfstoffe”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade